OVATION 3 is IMUNON’s pivotal Phase 3 study of IMMN-001, an IL-12 gene-mediated immunotherapy, in women with advanced stage epithelial ovarian cancer. The study is supported with unprecedented overall ...

Ascend Advanced Therapies (Ascend), a gene-to-GMP development partner, today announced that its European patent EP3722434, ...

VectorBuilder, a global leader in gene delivery technologies and CDMO services, today announced the publication of the miniVec plasmid system, engineered for safer, more efficient, and more scalable ...

By supporting sample prep across low-pass WGS, plasmid sequencing, and microbial sequencing, LongPlex extends options for researchers working in diverse fields. Its streamlined indexed tagmentation ...

The expansion of the patient monitoring accessories market is underpinned by several critical factors. The rapid increase in ...

Figure Technology Solutions Inc.’s stock rallied 24% in its first day of trading on Thursday in a sign of sustained interest by Wall Street in the fast-growing digital-currency sector. At the closing ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Get the latest news, claiming advice, and answers to frequently ...

Once again, AI dominates the agenda when it comes to discussing the most significant and impactful trends of the coming year. But with 2026 fast approaching, the conversation isn’t just around what AI ...

This past week the Ryder Cup was held at the famed Bethpage Black Golf Course in Farmingdale, New York. While the raucous crowd cheered the U.S. team, and European fans sang, “Ole, Ole,” Hewlett ...

Artist's concept of the Geovis space situational awareness (SSA) constellation. Credit: Geovis SYDNEY, Australia – A Chinese company plans to establish a constellation of 144 space situational ...

The Trump administration issued a rule to automatically extend trade restrictions for organizations on the “entity list” to any majority-owned subsidiary. By Ana Swanson Ana Swanson covers ...

This article is the first in a series discussing the results of Nature’s 2025 PhD survey. The next will look at what doctoral candidates wish they’d known when they set out on their degrees. The ...